← Evidence map

ReviewFrontiers in pharmacology2026

Orlistat: a comprehensive review of a lipase inhibitor from obesity management to emerging oncological applications.

Li Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 42812879